Licayan, Vilma .
HRN: 27-10-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/16/2025
06/23/2025
IVTT
2.25G
Q6H
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Choice Type Of Pneumonia Not Indicated
Final appropriateness: Yes
Overall appropriateness: Yes